LGC Standards strengthens its position in Asia with first China office
LGC Standards has opened its first office in Beijing, China. The new office will enable the company to bring its range of laboratory products and services to the Chinese market.
LGC Standards provides a range of products and services for measurement and laboratory control encompassing reference material distribution and proficiency testing, together with the production of pharmaceutical impurities and custom synthesis. For the first time the company will be able to support Chinese laboratories directly by offering logistical and technical advice in their local language.
The new office will be managed by Dr Chen Hong, who has over 10 years’ experience in major international companies. Dr Chen Hong obtained her degrees in analytical chemistry and biochemistry fields, and her PhD was obtained from the University of Tokyo in Japan. Mr Frank Lai also joins the company as a pharmaceutical specialist, with a bachelor’s degree from Shenyang pharmaceutical University, China and over seven years’ experience in pharmaceutical laboratories and industry.
Dr Matthias Brommer, Director, LGC Standards said: “The opening of our first Chinese office clearly demonstrates that LGC Standards is committed to providing global quality management solutions for laboratories worldwide. Our Chinese team will focus on supplying laboratories in the pharmaceutical, environmental, food, industrial and forensic sectors with reference materials and proficiency testing schemes to support laboratory quality.”
Topics
Organizations
Other news from the department business & finance
These products might interest you

Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
DSM Announces Biologics Development and Manufacturing Agreement for Australian Facility
Analytica China 2014: Closed with overall success - analytica China further strengthens its position as leading platform

More sensitive MRI diagnostics thanks to innovative “elastic” contrast media
Threading the Molecular Needle: ASU Biodesign Researcher to Explore Revolutionary Gene Sequencing - National Institutes of Health awarded a $550,000 three-year grant

Society for Clinical Data Management (SCDM) - Brüssel, Belgium
New gene transfer strategy shows promise for limb girdle and other muscular dystrophies
Computer simulation of protein malfunction related to Alzheimer's disease

AI tailors artificial DNA for future drug development - DNA molecules made-to-order: “What otherwise takes years is now shortened to weeks or days”

Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”

Bacterial soundtracks revealed by graphene membrane - Have you ever wondered if bacteria make distinctive sounds?
